Found 22 matching trials
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
PHASE3This study has been designed to evaluate the immunogenicity and safety of G...
Location
GSK Investigational Site
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females
PHASE2Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
PHASE3This study is designed to evaluate the immunogenicity and safety of GSK Bio...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
PHASE3This protocol posting deals with objectives \& outcome measures of the exte...
Location
GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
PHASE3Human papillomavirus (HPV) infection has been established as a necessary ca...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects
PHASE3This study is designed to evaluate the immunogenicity and safety of GlaxoSm...
Location
GSK Investigational Site
Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects
PHASE3This is a multicenter study in which women are planned to receive either th...
Location
GSK Investigational Site